期刊文献+

三磷酸腺苷结合盒运转体A1与颈动脉粥样硬化斑块的关系 被引量:6

Relation between ABCA1 expression and carotid atherosclerotic plaques
原文传递
导出
摘要 目的探讨三磷酸腺苷结合盒运转体 A1(ATP binding cassette transporter A1,ABCA1)在人颈动脉粥样硬化斑块中的表达变化及作用机制。方法收集24例人颈动脉粥样硬化斑块标本和10例肠系膜动脉标本(对照组),采用 RT-PCR 测定 ABCA1 mRNA 和视黄酸 X 受体α(RXRα)mRNA 表达水平,并采用 Western Blot 检测 ABCA1及 RXRα的蛋白表达水平。24例人颈动脉粥样硬化斑块标本按病理分级,比较病理组织为Ⅲ级和Ⅰ级动脉粥样硬化组织间 ABCA1 mRNA、RXRαmRNA 表达水平及蛋白表达水平。结果颈动脉粥样硬化斑块组的 ABCA1 mRNA(0.79±0.04)和RXRα mRNA(0.73±0.04)表达与对照组相比上调,差异有统计学意义(P<0.05);ABCA1 mRNA 与RXRα mRNA 增加水平相关(P<0.05);颈动脉粥样硬化斑块的 ABCA1蛋白表达(0.22±0.03)下调水平与对照组(0.53±0.03)相比差异有统计学意义(P<0.05);Ⅲ级和Ⅰ级动脉硬化斑块 ABCA1mRNA、RXRα mRNA 及蛋白表达水平差异有统计学意义(P<0.05)。结论 ABCA1及 RXRα蛋白表达水平下调可能是进展性动脉粥样硬化损害的关键因素。 Objective To investigate the changes of the expressions of ATP-binding cassette transporter A1 (ABCA1) and the retinoid X receptor (RXRα) in human carotid atherosclerotic plaques and to explore the possible mechanisms by which ABCA1 affects the formation of carotid atherosclerosis(CAS). Methods 24 carotid atherosclerotic plaque and 10 intestinal artery specimens were respectively collected to compared the expression levels of ABCA1 mRNA. RXRα mRNA and those protein, ABCA1 and RXRα gene expressions were determined by reverse transcriptase polymerase chain reaction (RT-PCR) in the specimens, meanwhile the presence of ABCA1 and RXRα protein was assessed by Western blot. Results ABCA1 (0. 79 ± 0. 04 ) and RXRα (0. 73 ±0. 04 ) gene expression were significantly elevated in carotid atherosclerotic plaques (P 〈 0.05, respectively). The increased levels of ABCA1 mRNA and RXRα mRNA were correlated with each other in carotid atherosclerotic tissue ( P 〈 0. 05 ). ABCA1 protein expression ( 0. 22 ± 0. 03 ) was significantly reduced in plaques compared with control tissues ( 0. 53 ± 0. 03, P 〈 0. 05 ). Moreover, there were significant differences of levels of ABCA1 mRNA and RXRα mRNA and the proteins between plaques of Ⅰ and Ⅲ pathological grades. Conclusions Despite the significant upregulation of ABCA1 mRNA and RXRα mRNA, ABCA1 and RXRα protein are markedly reduced in advanced carotid atherosclerotic lesions. These findings suggest that the decreased level of ABCA1 and RXRα protein might play a key role in the pathogenesis of CAS.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第3期187-189,共3页 Chinese Journal of Neurology
关键词 颈动脉疾病 ATP结合匣式转运子 受体 维甲酸 Carotid artery disease ATP binding cassette transporters Receptors, restinoic acid
  • 相关文献

参考文献9

  • 1Takahashi K, Kimura Y, Nagata K, et al. ABC proteins: key molecules for lipid homeostasis. Med Mol Morphol, 2005,38 : 2-12.
  • 2张乐,杨期东,曾艺,杜小平,周艳宏,夏健,刘运海,许宏伟.载脂蛋白B基因C7673T突变与有家族聚集现象脑梗死的关系[J].中华神经科杂志,2005,38(12):784-785. 被引量:5
  • 3Attie AD, Hamon Y, Brooks-Wilson AR, et al. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken.J Lipid Res,2002,43 : 1610-1617.
  • 4Aiello RJ, Brees D, Bourassa PA, et al. Increased atherosclerosis in hyper-lipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vase Biol, 2002,22:630-637.
  • 5Norata GD, Onari M, Uboldi P, et al. Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipidmetabolism in human endothelial cells. Int J Mol Med, 2005,16:717-722.
  • 6Hajj Hassan H, Blain S, Boucher B, et al. Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release. J Lipid Res, 2005, 46 : 1457-1465.
  • 7Frikke-Schmidt R, Nordestgaard BG, Jensen GB, et al. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest ,2004,114 : 1343-1353.
  • 8Albrecht C, Soumian S, Amey JS, et al. ABCAI expression in carotid atherosclerotic plaques. Stroke ,2004,35: 2801-2806.
  • 9Lawn RM, Wade DP, Couse TL, et al. Localization of human ATP-binding cassette transporter 1 (ABCI) in normal and atherosclerotic tissues. Arterioscler Thromb Vase Biol, 2001,21 :378-385.

二级参考文献7

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33093
  • 2Wick U,Witt E,Engel W.Restriction fragment length polymorphisms at the apolipoprotein genes AⅠ,CⅢ,and B-100 and in the 5′flanking region of the insulin gene as possible markers of coronary heart disease.Clin Genet,1995,47:184-190.
  • 3Saha N,Tay JS,Humphries SE.Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI),serum lipids,and apolipoprotein in healthy Chinese.Genet Epidemiol,1992,9:1-10.
  • 4Meschia JF,Atkinson EJ,O' Brien PC,et al.Familial clustering of stroke according to proband age at onset of presenting ischemic stroke.Stroke,2003,34:89-91.
  • 5Chen Z,Fitzgerald RL,Saffitz JE,et al.Amino terminal 38.9% of apolipoprotein B-100 is sufficient to support cholesterol-rich lipoprotein production and atherosclerosis.Arterioscler Thromb Vasc Biol,2003,23:668-674.
  • 6Baroni MG,Berni A,Romeo S,et al.Genetic study of common variants at the Apo E,Apo AⅠ,Apo CⅢ,Apo B,lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD):variation in LIPC gene associates with clinical outcomes in patients with established CAD.BMC Med Genet,2003,4:8.
  • 7Bohn M,Berg K.The XbaI polymorphism at the apolipoprotein B and risk of atherosclerotic disease.Clin Genet,1994,46:77-79.

共引文献4

同被引文献37

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部